Skip to main content
SpringerLink
Log in
Book cover

Supported Complex and High Risk Coronary Angioplasty pp 21–32Cite as

Myocardial Protection During Coronary Angioplasty

  • Chapter

  • 49 Accesses

Part of the book series: Interventional Cardiology ((INCA,volume 1))

Abstract

Since Dr, Andreas Gruentzig’s initial description in 1977 of this innovative therapeutic technique, percutaneous transluminal coronary angioplasty (PTCA) has revolutionized the practice of cardiology [1]. Originally envisioned by its creator as a less traumatic alternative to coronary bypass surgery for a select subset of patients with single-vessel disease, PTCA is now considered a mainstream therapy for angina with multivesscl disease, unstable angina, acute myocardial infarction, and post-bypass surgery angina [2].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gruntzig AR, Senning A, Siegenthaler WF. Nonoperative dilatation of coronary artery stenosis: Percutaneous transluminal coronary angioplasty.N Engl J Med1979; 301:61–68.

    Article  PubMed  CAS  Google Scholar 

  2. Holmes DR, Vlictstra RE, Percutaneous transluminal coronary angioplasty: Current status and future trends.Mayo Clin Proc1986; 61:865–876.

    PubMed  Google Scholar 

  3. Wohlgelernter I, Clernan M, Highman HA, Fetterman RC, Duncan JS, Zaret BL, Jaffe CC. Regional myocardial dysfunction during coronary angioplasty: Evaluation by two-dimensional echocardiography and 12 lead electrocardiography. JAtn Coll Cordial1986; 7:1245–1254.

    Article  Google Scholar 

  4. Hauser AM, Gangadharan V, Ramos RG, Gordon S, Timrnis GC. Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: Echocardiographic observations during coronary angioplasty. J AmColl Cardiol1985; 5:193–197.

    Article  PubMed  CAS  Google Scholar 

  5. Visser CA, David GK, Kan G, Romijn KH, Meiner RS, Koolen JJ, Dunning AJ Two-dimensional echocardiography during percutancous transluminal coronary angioplastyAm Heart)1986; 111:1035–1041.

    Article  CAS  Google Scholar 

  6. Alam M, Khaja F, Brymer J, Marzelli M, Goldstein S. Echocardiographic evaluation of left ventricular function during coronary artery angioplasty. Am]Cordial1986; 57:20–25.

    Article  CAS  Google Scholar 

  7. Opie LH. Metabolism of the heart in health and disease. Part I.An¡ Heart]1968; 76:685–698.

    Article  CAS  Google Scholar 

  8. Serruys PW, Wijns W, van den Brand M, Meij S, Slager C, Schuurbiers JCH, Hugenholtz PG, Brower RW. Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty.Circulation1984; 70:25–36.

    Article  PubMed  CAS  Google Scholar 

  9. Bowman LK, Cleman MW, Cabin HS, Zaret BL, Jaffe CC. Dynamics of early and late left ventricular filling determined by Doppler two-dimensional echocardiography during percutaneous transluminal coronary angioplasty.Am J Cardiol1988; 61:541–545.

    Article  PubMed  CAS  Google Scholar 

  10. Wijns W, Scrruys PW, Slager CJ, Orimm J, Krayenhuehl HP, Hugenholtz PG, Hess OM. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. J AmColl Cardin1986; 455–463.

    Google Scholar 

  11. Simon R, Amede I, Lichtlen PR. Coronary blood flow and hemodynamics during prolonged balloon inflation in coronary angioplasty.J Am Coll Cordial1984; 3:507A.

    Google Scholar 

  12. Wohlgelernter I, Jaffe CC, Cabin HS, Yeatman LA, Ciernan M. Silent ischemia during coronary occlusion produced by balloon inflation: Relation to regional myocardial dysfunction.J Am Coll Cordial1987; 10:491–498.

    Article  CAS  Google Scholar 

  13. The National Heart, Lung and Blood Institute Registry. Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981.N EnQl J Med 1988;318:265–270.

    Google Scholar 

  14. Doorey AJ, Mehmel HC, Schwarz FX, Kubler W. Amelioration by nitroglycerin of left ventricular ischemia induced by percutaneous transluminal coronary angioplasty: Assessment by hemodynamic variables and left ventriculography. JAet Coll Cardin!1985; 6:267–274.

    Article  CAS  Google Scholar 

  15. Feldman RL, MacDonald RG, Hill JA, Limacher MC, Conti CR, Pepine CJ. Effect of propranolol on myocardial ischemia occurring during acute coronary occlusion.Circulation1986; 73:727–733.

    Article  PubMed  CAS  Google Scholar 

  16. Zalewski A, Goldberg S, Dervan JP, Slysh S, Maroko PR. Myocardial protection during transient coronary artery occlusion in man: Beneficial effects of regional beta-adrenergic blockade.Circulation1986; 73:734–739.

    Article  PubMed  CAS  Google Scholar 

  17. Feldman RL, MacDonald RG, Hill JA, Pepine CJ. Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty.Am J Cardiol1987; 60:267–270.

    Article  PubMed  CAS  Google Scholar 

  18. Hanet C, Rousseau MF, Vincent MF, Lavenne-Pardonge E, Pouleur H. Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.Am J Cardle!1987; 1035–1040.

    Google Scholar 

  19. Kober G, Kastner R, Hopf R, Kaltenbach M. Die direkte myokardiale antiischamische wirkung von diltiazem beim menschen.Z Kardiol1986; 75:386–393.

    PubMed  CAS  Google Scholar 

  20. Pop G, Serruys PW, Piscione F, de Feyter P, van den Brand M, Huizer T, de Jong JW, Hugenholtz PG. Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty. Int JCardiol1987; 16:27–41.

    CAS  Google Scholar 

  21. Kern MJ, Deligonul U, Labovitz A. Effects of diltiazem and nifedipine on systemic and coronary hemodynamics and ischemic responses during transient coronary artery occlusion in patients.Am Heart J1990; 119:47–54.

    Article  PubMed  CAS  Google Scholar 

  22. Timmis AD, Crick JCP, Griffin B. Arterial blood infusion for myocardial protection during PTCA. JAm Coll Cardiol1986; 7:105A.

    Google Scholar 

  23. Angelini P, Heibig J, Leachman R. Distal hemoperfttsion during percutaneous transluminal coronary angioplasty. Am JCardiol1986; 58:252–255.

    Article  CAS  Google Scholar 

  24. Ciernan M, Jaffe CC, Wohlgelernter D. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.Cirrnlarion1986; 74:555–562.

    Google Scholar 

  25. Jaffe CC, Wohlgelernter D, Cabin H, Bowman L, Deckelbaum L, Remus M, Cleman M. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.Asti Heart)1988; 115:1156–1164.

    Article  CAS  Google Scholar 

  26. Cowley MJ, Snow FR, DiSciascio G, Kelly K, Guard C, Nixon JV. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients.Circulation1990; 81(Suppl. IV)27–34.

    Google Scholar 

  27. Turi ZG, Campbell CA, Gottimukkala MV, Kioner RA. Preservation of distal coronary perfusion during prolonged balloon inflation with an autoperfusion angioplasty catheter.Circulation1987; 75:1273–1280.

    Article  PubMed  CAS  Google Scholar 

  28. Quigley PJ, Hinohara T, Phillips HR, Peter RH, Behar VS, Kong Y, Simonton CA, Perez JA, Stack RS. Myocardial protection during coronary angioplasty with an autoperfusion balloon catheter in humans.Circulation1988; 78:1128–1134.

    Article  PubMed  CAS  Google Scholar 

  29. Muhlestein JB, Quigley PJ, Phillips HR, Smith JE, Enos SM, Navetta FI, Tcheng JE, Stack RS. Does myocardial damage or hemolysis occur during prolonged perfusion balloon angioplasty? JAmCollCardiol1990; 15:250A.

    Google Scholar 

  30. Meerbaum S, Lang TW, Other JV, Hashimoto K, Lewis GW, Feldstein C, Corday E. Diastolic retroperfusion of acutely ischemic myocardium.Am J Cardiol1976; 37:588–597.

    Article  PubMed  CAS  Google Scholar 

  31. Berland J, Farcot JC, Barrier A, Dellac A, Gamra H, Letac B. Coronary venous synchronized retroperfusion during percutaneous transluminal angioplasty of left anterior descending coronary artery.Circulation1990; 81(Suppl. IV):35–42.

    Google Scholar 

  32. Voudris V, Marco J, Morice MC, Fajadet J, Royer T. “High-risk” percutaneous transluminal coronary angioplasty with preventive intra-aortic balloon counterpulsation.Gather Cardiovasc Diag1990; 19:160–164.

    Article  CAS  Google Scholar 

  33. Shani J, Hollander G, Nathan I, Greengart A, Toporoff B, Jacobowitz I, Glassman E, Cunningham J, Lichstein E. Percutaneous left atrial-femoral artery bypass with a pulsatile pump: Initial experience in cardiogenic shock. JAPI Col! Cardiol1989; 13:53A.

    Google Scholar 

  34. Loisance D, Dubois-Rande JL, Deleuze P, Okude J, Rosenval O, Geschwind H. Prophylactic intraventricular pumping in high-risk coronary angioplasty.Lancet1980; 335:438–440.

    Article  Google Scholar 

Download references

Authors
  1. Daniel Wohlgelernter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Interventional Cardiology, Washington Adventist Hospital, Takoma Park, Maryland, USA

    Fayaz A. Shawl M.D., FACC (Director) (Director)

  2. George Washington University School of Medicine, Washington D.C., USA

    Fayaz A. Shawl M.D., FACC (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wohlgelernter, D. (1991). Myocardial Protection During Coronary Angioplasty. In: Shawl, F.A. (eds) Supported Complex and High Risk Coronary Angioplasty. Interventional Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3890-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3890-5_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6735-2

  • Online ISBN: 978-1-4615-3890-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation